1. Ishikawa M, Shibata T, Iwata T, Nishio S, Takada T, Suzuki S, Horie K, Kudaka W, Kagabu M, Tanikawa M, Kitagawa R, Takekuma M, Kobayashi H, Yaegashi N; Japan Clinical Oncology Group. A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis. Gynecol Oncol. 2021, 162, 292-298. doi: 10.1016/j.ygyno.2021.05.007.
2. Yoshida H, Naka T, Kobayashi-Kato M, Kikkawa N, Tanase Y, Uno M, Ishikawa M, Kato T. Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas? Virchows Arch. 2021, 479, 407-412. doi: 10.1007/s00428-020-02997-0.
3. Nishio S, Matsuo K, Nasu H, Murotani K, Mikami Y, Yaegashi N, Satoh T, Okamoto A, Ishikawa M, Miyamoto T, Mandai M, Takehara K, Yahata H, Takekuma M, Ushijima K. Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study. Eur J Surg Oncol. 2022, 25:S0748-7983(22)00129-9. doi: 10.1016/j.ejso.2022.03.007.
4. Shimada M, Tsuji K, Shigeta S, Nagai T, Watanabe Z, Tokunaga H, Kigawa J, Yaegashi N. Rethinking the significance of surgery for uterine cervical cancer. The Journal of Obstetrics and Gynaecology Research. 2022, 48(3), 576-86, doi: 10.1111/jog.15112.
5. Ikeda M, Shida M, Shigeta S, Nagase S, Takahashi F, Yamagami W, Katabuchi H, Yaegashi N, Aoki D, Mikami M. The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee. Journal of Gynecologic Oncology. 2021, 32(3), e44, doi: 10.3802/jgo.2021.32.e44.
6. Iwata T, Machida H, Matsuo K, Okugawa K, Saito T, Tanaka K, Morishige K, Kobayashi H, Yoshino K, Tokunaga H, Ikeda T, Shozu M, Yaegashi N, Enomoto T, Mikami M. The validity of the subsequent pregnancy index score for fertility-sparing trachelectomy in early-stage cervical cancer. Fertility and Sterility. 2021, 115(5), 1250-58, doi: 10.1016/j.fertnstert.2020.09.162.
7. Miyahara S, Tsuji K, Shimada M, Shibuya Y, Shigeta S, Nagai T, Umezawa R, Tokunaga H, Jingu K, Yaegashi N. The impact of histological subtype on survival outcome of patients with stage IIB-IVA cervical cancer who received definitive radiotherapy. The Tohoku Journal of Experimental Medicine. 2021, 255(4), 303-13, doi: 10.1620/tjem.255.303.
8. Ohta T, Nagase S, Okui Y, Enomoto T, Yamagami W, Mikami M, Tokunaga H, Ino K, Ushijima K, Shozu M, Tashiro H, Mandai M, Miyamoto S, Morishige KI, Yoshida Y, Yoshino K, Saito T, Kobayashi E, Kobayashi H, Takekuma M, Terai Y, Fujii T, Kanao H, Aoki D, Katabuchi H, Yaegashi N. Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan. International Journal of Clinical Oncology. 2021, 26(12), 2318-30, doi: 10.1007/s10147-021-02017-4.
9. Toyoshima M, Shimada M, Sasaki S, Ishibashi M, Shigeta S, Tsuji K, Nagai T, Tokunaga H, Niikura H, Yaegashi N. A single arm prospective pilot study examining the efficacy and safety of bevacizumab single maintenance therapy following platinum-based chemotherapy in patients with advanced or recurrent cervical cancer. The Tohoku Journal of Experimental Medicine. 2021, 254(3), 145-53, doi: 10.1620/tjem.254.145.
10. Tsuji K, Shimada M, Takahashi F, Tokunaga H, Deura I, Yamaguchi S, Nakanishi T, Matsuo K, Yaegashi N, Mikami M. Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan. International Journal of Clinical Oncology. 2021, 26(8), 1541-52, doi: 10.1007/s10147-021-01938-4.